Back to Results
First PageMeta Content



Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners Lausanne, Switzerland, September 29th, 2015. Asceneuron SA, an emerging leader in the development of first-in-class small molecules
Add to Reading List

Document Date: 2015-09-29 04:05:37


Open Document

File Size: 335,59 KB

Share Result on Facebook